Kelfer 500 Capsule contains Deferiprone 500 mg, an oral iron chelator primarily indicated for the treatment of iron overload in patients with conditions such as thalassemia major who require regular blood transfusions. Deferiprone acts by binding excess free iron in the bloodstream, forming a complex that is subsequently excreted via the urine, thereby reducing the toxic effects of iron accumulation in vital organs including the heart, liver, and endocrine glands. This medication is particularly beneficial in preventing and managing hemosiderosis, a condition characterized by iron-induced tissue damage. Kelfer 500 Capsule should be administered under strict medical supervision, with regular monitoring of serum ferritin levels, liver function tests, and complete blood counts to detect potential adverse effects such as neutropenia or agranulocytosis. Common side effects may include gastrointestinal disturbances, arthralgia, and transient elevations in liver enzymes. Patients are advised to adhere to prescribed dosing schedules and report any signs of infection or unusual symptoms promptly. Kelfer 500 Capsule is contraindicated in patients with hypersensitivity to Deferiprone or those with severe hepatic or renal impairment. Its use requires careful risk-benefit assessment, particularly in pregnant or lactating women.